<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Post-thrombotic (postphlebitic) syndrome
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Post-thrombotic (postphlebitic) syndrome
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Post-thrombotic (postphlebitic) syndrome
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Susan R Kahn, MD, MSc, FRCPC
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Barbara M Mathes, MD, FACP, FAAD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John F Eidt, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joseph L Mills, Sr, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kathryn A Collins, MD, PhD, FACS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Mar 09, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Post-thrombotic syndrome refers to symptoms and signs of chronic venous insufficiency that develop following deep vein thrombosis (DVT) and is a common, burdensome, and costly complication [
         <a href="#rid1">
          1,2
         </a>
         ]. The term "post-thrombotic" replaces the prior terminology "postphlebitic" syndrome [
         <a href="#rid3">
          3
         </a>
         ]. A combination of reflux due to valvular incompetence and venous hypertension due to thrombotic obstruction is thought to underlie the pathophysiology of post-thrombotic syndrome [
         <a href="#rid4">
          4,5
         </a>
         ]. Symptoms and signs of post-thrombotic syndrome may include leg pain, leg heaviness, vein dilation, edema, skin pigmentation, and venous ulcers. Our approach to the diagnosis, treatment, and prevention of post-thrombotic syndrome is in broad agreement with published guidelines from the American Heart Association [
         <a href="#rid6">
          6
         </a>
         ]. Prevention of DVT through thromboprophylaxis, timely recognition and treatment of DVT, and prevention of recurrent DVT will continue to have the greatest impact on reducing the overall burden of post-thrombotic syndrome [
         <a href="#rid7">
          7
         </a>
         ]. The treatment of lower extremity DVT is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1362.html" rel="external">
          "Overview of the treatment of proximal and distal lower extremity deep vein thrombosis (DVT)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H234405781">
         <span class="h1">
          PATHOPHYSIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Post-thrombotic syndrome develops as a consequence of long-standing venous hypertension [
         <a href="#rid7">
          7
         </a>
         ]. A combination of reflux due to valvular incompetence and venous hypertension due to thrombotic obstruction is thought to contribute to post-thrombotic syndrome [
         <a href="#rid4">
          4,5
         </a>
         ]. One study identified a high peak reflux velocity in the deep proximal veins as an independent predictor of post-thrombotic syndrome [
         <a href="#rid8">
          8
         </a>
         ]. Increased venous pressures are transmitted to the capillary beds, promoting transudation of fluid and large molecules, resulting in tissue edema, subcutaneous fibrosis, and, finally, tissue hypoxia and ulceration [
         <a href="#rid9">
          9-11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8202.html" rel="external">
          "Pathophysiology of chronic venous disease"
         </a>
         .)
        </p>
        <p>
         Acute deep vein thrombosis (DVT) causes obstruction of venous outflow, which can be partial or complete. Vein wall remodeling as a consequence of venous thrombosis, as identified in ultrasound studies, appears to be directly related to the thrombus [
         <a href="#rid12">
          12
         </a>
         ]. Increased levels of inflammatory cytokines or adhesion molecules, such as interleukin-6 and intercellular adhesion molecule-1, have also been linked with the development of post-thrombotic syndrome, suggesting that inflammation may play a role in the pathophysiology of post-thrombotic syndrome [
         <a href="#rid13">
          13-15
         </a>
         ]. The inflammatory response to acute thrombosis and the process of recanalization directly damages venous valves.
        </p>
        <p>
         Reflux occurs early, progressively increasing from 17 percent of patients at one week to 69 percent of patients at one year following the diagnosis of DVT [
         <a href="#rid16">
          16
         </a>
         ]. The degree of initial vein occlusion correlates with the likelihood of developing reflux [
         <a href="#rid16">
          16
         </a>
         ]. Reflux in the more proximal lower extremity veins may be particularly important to the development of post-thrombotic syndrome. However, popliteal valve incompetence has also been found to increase the risk of post-thrombotic syndrome, particularly when combined with residual vein thrombosis [
         <a href="#rid17">
          17,18
         </a>
         ]. (See
         <a class="local">
          'Risk factors'
         </a>
         below.)
        </p>
        <p>
         Recanalization is a complex process involving intrinsic events within the thrombus and is related to an increase in endogenous fibrinolysis [
         <a href="#rid19">
          19,20
         </a>
         ]. An inverse relationship between levels of fibrinolytic inhibitors and the degree of recanalization has been described [
         <a href="#rid19">
          19
         </a>
         ]. Over time, the amount of thrombus decreases, and in some cases, the lumen reestablishes itself (ie, recanalization). More rapid resolution of thrombus may preserve valvular function [
         <a href="#rid21">
          21-23
         </a>
         ]. Recanalization can be seen as early as six weeks from diagnosis [
         <a href="#rid24">
          24,25
         </a>
         ], but approximately one half of legs have residual thrombus causing partial obstruction [
         <a href="#rid26">
          26
         </a>
         ]. The rate of recanalization appears to be related to the initial thrombus load [
         <a href="#rid26">
          26
         </a>
         ] and thrombus site with distal thrombi undergoing more rapid and complete resolution [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The reported incidence of post-thrombotic syndrome varies widely, in part due to inhomogeneous patient populations and diagnostic criteria. Older studies reported rates up to 100 percent; contemporary studies cite incidences ranging from 20 to 80 percent [
         <a href="#rid7">
          7,28,29
         </a>
         ]. Among studies that use validated diagnostic criteria, the incidence is approximately 50 percent in the first year in spite of anticoagulation [
         <a href="#rid18">
          18
         </a>
         ]. Severe post-thrombotic syndrome occurs in 5 to 10 percent of patients [
         <a href="#rid29">
          29,30
         </a>
         ].
        </p>
        <p>
         Most patients who develop post-thrombotic syndrome become symptomatic within two years from the acute episode [
         <a href="#rid7">
          7,31
         </a>
         ]. However, the incidence of severe post-thrombotic syndrome progressively accumulates. In a study of 93 patients who were followed for six years, the incidence of the post-thrombotic syndrome was 49 percent after one year and 55 percent after two years, without further increase up to six years [
         <a href="#rid18">
          18
         </a>
         ]. In a larger prospective study, the cumulative incidence of post-thrombotic syndrome at one, two, and five years was 17, 23, and 28 percent, respectively; these percentages did not increase thereafter [
         <a href="#rid32">
          32
         </a>
         ]. The incidence of severe skin changes indicative of chronic venous insufficiency, including venous ulcer, increased from 2.6 percent at one year to 9.3 percent at five years.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Observational studies identify various factors that influence the risk of developing the post-thrombotic syndrome [
         <a href="#rid33">
          33-38
         </a>
         ]. In general, factors that are thought to be important to the development of post-thrombotic syndrome can be broadly characterized as patient specific, related to the inciting deep vein thrombosis (DVT), or related to the treatment of DVT, and are discussed below [
         <a href="#rid39">
          39
         </a>
         ]. Ongoing research seeks to identify biological markers that may predict the risk of post-thrombotic syndrome in individual patients.
        </p>
        <p>
         A model to identify patients at highest risk of developing post-thrombotic syndrome has been developed and validated [
         <a href="#rid40">
          40,41
         </a>
         ]. High-risk predictors were index DVT in the iliac vein, body mass index of ≥35 kg/m
         <sup>
          2
         </sup>
         , and moderate-severe Villalta severity category at DVT diagnosis. Compared with patients with a score of 0, those with a score of ≥4 had an odds ratio of 5.9 for developing post-thrombotic syndrome.
        </p>
        <p class="headingAnchor" id="H436298064">
         <span class="h3">
          Patient-specific
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patient-specific factors that may increase the risk for post-thrombotic syndrome include preexisting primary venous insufficiency, older age [
         <a href="#rid42">
          42,43
         </a>
         ], obesity [
         <a href="#rid33">
          33,34,44
         </a>
         ], and varicose veins [
         <a href="#rid33">
          33,45
         </a>
         ]. There does not appear to be a consistent relationship between sex and the development of post-thrombotic syndrome [
         <a href="#rid33">
          33-35,39,42,43,46
         </a>
         ].
        </p>
        <p>
         Thrombophilia does not appear to increase the risk for developing post-thrombotic syndrome [
         <a href="#rid30">
          30,32-34,42,47
         </a>
         ]. In one retrospective review of 677 patients, no significant differences in the incidence of post-thrombotic syndrome were seen between those patients with thrombophilia (antithrombin, protein C and S deficiencies, lupus anticoagulant, factor V Leiden) compared with those without thrombophilia [
         <a href="#rid47">
          47
         </a>
         ]. However, this is controversial as there are data in favor of an association as well [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h3">
          Related to DVT characteristics
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Primary versus recurrent DVT – The development of recurrent ipsilateral DVT is strongly associated with the risk for post-thrombotic syndrome [
         <a href="#rid32">
          32,34,48,49
         </a>
         ]. The risk for post-thrombotic syndrome is increased up to sixfold, likely due to worsened venous outflow obstruction and damage to already compromised valves. Other poor prognostic factors include the combination of reflux and obstruction and multisegmental venous involvement [
         <a href="#rid50">
          50
         </a>
         ]. This suggests that prevention of recurrent thrombosis is the most important intervention to prevent post-thrombotic syndrome in patients presenting with DVT.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Symptomatic versus asymptomatic DVT – The incidence of post-thrombotic syndrome is probably lower after asymptomatic DVT, such as that detected on postoperative screening [
         <a href="#rid51">
          51
         </a>
         ]. A systematic review concluded that asymptomatic postoperative DVT still substantially increases the risk of post-thrombotic syndrome; however, there was evidence of significant publication bias in the review [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Proximal versus distal DVT – Several studies have found a greater absolute risk of trophic skin changes following venous thrombosis for proximal compared with distal thrombosis, and with deep or combined deep and superficial thrombosis compared with only superficial thrombosis [
         <a href="#rid34">
          34,35,53-58
         </a>
         ]. However, other studies have not demonstrated a greater risk for proximal over distal thrombosis [
         <a href="#rid32">
          32,59
         </a>
         ]. It is important to note that "proximal" DVT has included both iliofemoral and femoropopliteal thrombosis. In a study of 387 patients followed over three years, patients with more extensive proximal (femoral or iliac vein) DVT had significantly worse post-thrombotic syndrome scores at all visits (adjusted average increase of &gt;2 points on the Villalta scale) than those with distal or popliteal DVT [
         <a href="#rid34">
          34
         </a>
         ]. Similarly, proximal DVT increased the risk for post-thrombotic syndrome twofold compared with distal DVT [
         <a href="#rid35">
          35
         </a>
         ]. Symptoms of post-thrombotic syndrome after distal DVT appear to be milder [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Residual thrombus – Residual thrombus within the first six months after the thrombotic episode appears to be an important risk factor for post-thrombotic syndrome. In a study of 180 patients who were followed for at least three years after an episode of acute proximal DVT, post-thrombotic syndrome developed in 24 percent without vein abnormalities, but in 47 percent with at least one abnormality [
         <a href="#rid17">
          17
         </a>
         ]. The incidence of post-thrombotic syndrome was 48 percent in patients with residual vein thrombosis, 27 percent in patients with popliteal vein valve incompetence, and 54 percent in patients with both. In a substudy of the IDEAL DVT trial, post-thrombotic syndrome was significantly less prevalent in patients without residual vein obstruction (46 versus 54 percent) [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H436298591">
         <span class="h3">
          Related to DVT treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Minimizing the development of post-thrombotic syndrome is related to timely and adequate pharmacologic treatment of DVT. (See
         <a class="medical medical_review" href="/z/d/html/1362.html" rel="external">
          "Overview of the treatment of proximal and distal lower extremity deep vein thrombosis (DVT)"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Antithrombotic treatment – The risk of post-thrombotic syndrome is greater in patients who do not maintain adequate anticoagulation during initial treatment for their DVT [
         <a href="#rid36">
          36,42,62
         </a>
         ]. The risk may also vary depending upon the type of anticoagulant used [
         <a href="#rid63">
          63-66
         </a>
         ]. Antithrombotic therapy for the treatment of DVT is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/1362.html" rel="external">
          "Overview of the treatment of proximal and distal lower extremity deep vein thrombosis (DVT)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In one study comparing patients whose international normalized ratio (INR) was subtherapeutic (&lt;2.0) with those whose INR was ≥2.0 for more than 50 percent of readings in the first three months of treatment, the risk of the post-thrombotic syndrome was significantly increased over five-year follow-up (odds ratio 2.71, 95% CI 1.44-5.10) [
         <a href="#rid42">
          42
         </a>
         ]. In a later study, the overall frequency of post-thrombotic syndrome in patients with subtherapeutic anticoagulation was 33.5 percent, compared with 21.6 percent in those with an INR below 2.0 for ≤20 percent of the time [
         <a href="#rid62">
          62
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Due to their rapid onset, ease of administration, and more predictable pharmacokinetics, direct oral anticoagulants (DOACs), such as
         <a class="drug drug_general" data-topicid="8926" href="/z/d/drug information/8926.html" rel="external">
          dabigatran
         </a>
         ,
         <a class="drug drug_general" data-topicid="9498" href="/z/d/drug information/9498.html" rel="external">
          rivaroxaban
         </a>
         ,
         <a class="drug drug_general" data-topicid="85642" href="/z/d/drug information/85642.html" rel="external">
          apixaban
         </a>
         , and
         <a class="drug drug_general" data-topicid="99275" href="/z/d/drug information/99275.html" rel="external">
          edoxaban
         </a>
         , could be associated with more effective anticoagulation and a reduced incidence of post-thrombotic syndrome [
         <a href="#rid63">
          63,66
         </a>
         ]. Support for this hypothesis comes from experimental evidence and suggests that direct thrombin inhibitors and factor Xa inhibitors hasten clot lysis compared with
         <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">
          warfarin
         </a>
         . A post-hoc analysis of a clinical trial and another observational study suggest that post-thrombotic syndrome may be less frequent in patients with DVT treated with DOACs [
         <a href="#rid64">
          64,66
         </a>
         ]. Prospective confirmation from large clinical trials is lacking [
         <a href="#rid65">
          65
         </a>
         ]. However, in a review of 349 patients included in the RE-COVER study, the prevalence of post-thrombotic syndrome was similar for 166 patients treated with dabigatran compared with 183 treated with warfarin [
         <a href="#rid67">
          67
         </a>
         ]. A meta-analysis reported a lower incidence of PTS after DVT treated with rivaroxaban compared with warfarin [
         <a href="#rid68">
          68
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The risk of developing venous ulceration may be lower in patients treated with low-molecular-weight heparin compared with oral anticoagulation, which could be due to more consistent anticoagulation. A pooled analysis of two trials found a lower risk of self-reported skin ulcers in patients treated with low-molecular-weight heparin (risk ratio 0.13, 95% CI 0.02-0.71) [
         <a href="#rid69">
          69
         </a>
         ]. Vein recanalization rates following DVT were also higher in patients receiving low-molecular-weight heparin [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thrombolysis – Post-thrombotic complications develop predominantly in those patients in whom the initial DVT-related venous symptoms tend to persist [
         <a href="#rid34">
          34
         </a>
         ]. The use of thrombolytic therapy to treat acute proximal DVT may decrease the risk of post-thrombotic syndrome by reducing clot burden or possibly preventing proximal vein valve dysfunction [
         <a href="#rid21">
          21,71,72
         </a>
         ]. In a trial that randomly assigned 692 patients with acute proximal DVT to anticoagulation alone or anticoagulation plus pharmacomechanical thrombolysis, the overall incidence of post-thrombotic syndrome was similar as were quality of life measures. However, moderate-to-severe post-thrombotic syndrome occurred in fewer patients in the thrombolysis group compared with the control group (18 versus 24 percent; risk ratio 0.73; 95% CI 0.54-0.98). There were more major bleeding events within 10 days in the thrombolysis group (1.7 versus 0.3 percent). A smaller trial that evaluated ultrasound-accelerated catheter-directed thrombolysis had similar results [
         <a href="#rid72">
          72
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15223.html" rel="external">
          "Overview of iliocaval venous obstruction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/110055.html" rel="external">
          "May-Thurner syndrome"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15222.html" rel="external">
          "Endovenous intervention for iliocaval venous obstruction"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Graduated compression stockings – Graduated compression stockings can be used following the development of lower extremity DVT to improve lower extremity symptoms such as edema. However, there are conflicting data on the long-term effectiveness of graduated compression stockings for preventing post-thrombotic syndrome. While two older small open-label trials reported that elastic compression stockings were effective for preventing post-thrombotic syndrome [
         <a href="#rid43">
          43,73
         </a>
         ], a later large, multicenter trial showed no evidence of benefit of active compression stocking used for two years [
         <a href="#rid74">
          74
         </a>
         ]. Thus, routine use of compression stockings for two years to prevent post-thrombotic syndrome in patients with DVT is no longer recommended. In the IDEAL-DVT trial, an individualized duration of therapy based on post-thrombotic symptoms/signs was noninferior to the standard 24 month duration of therapy [
         <a href="#rid75">
          75
         </a>
         ]. In a subanalysis of the IDEAL-DVT trial, patients who received compression therapy immediately after DVT had a significantly lower percentage of residual vein obstruction (46.3 versus 66.7 percent) [
         <a href="#rid61">
          61
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1362.html" rel="external">
          "Overview of the treatment of proximal and distal lower extremity deep vein thrombosis (DVT)", section on 'Supportive therapies'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          CLINICAL FEATURES
         </span>
        </p>
        <p class="headingAnchor" id="H13830351">
         <span class="h2">
          Symptoms and signs
         </span>
         <span class="headingEndMark">
          —
         </span>
         Symptoms of post-thrombotic syndrome may be intermittent or persistent, may appear several weeks or months following a deep venous thrombosis, or may continue without interruption following an acute event [
         <a href="#rid10">
          10
         </a>
         ]. The clinical manifestations of post-thrombotic syndrome are nonspecific but are essentially those of chronic venous disease and are discussed in detail separately. Summarized briefly, symptoms and signs can include extremity pain, heaviness, venous dilation, edema, pigmentation, trophic skin changes, and venous ulcers [
         <a href="#rid76">
          76
         </a>
         ]. Edema occurs in approximately two thirds of patients with post-thrombotic syndrome, skin pigmentation in approximately one third, and venous ulceration in less than 5 percent. Trophic changes tend to occur between two and four years after deep vein thrombosis (DVT), with no further changes between 5 and 12 years [
         <a href="#rid4">
          4,32
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8198.html" rel="external">
          "Clinical manifestations of lower extremity chronic venous disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13830357">
         <span class="h3">
          Scoring systems
         </span>
         <span class="headingEndMark">
          —
         </span>
         The Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification is useful for characterizing chronic venous disease. Classification systems used in the diagnosis and management of lower extremity chronic venous disease are reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/8177.html" rel="external">
          "Classification of lower extremity chronic venous disorders", section on 'CEAP classification'
         </a>
         .)
        </p>
        <p>
         The clinical severity of post-thrombotic syndrome has been scored using the Villalta score, which has been recommended as an international standard to diagnose and classify the severity of post-thrombotic syndrome [
         <a href="#rid1">
          1,76
         </a>
         ]. A higher score indicates a greater severity of post-thrombotic syndrome, with a score of &gt;15 suggesting severe post-thrombotic syndrome. (See
         <a class="medical medical_review" href="/z/d/html/8177.html" rel="external">
          "Classification of lower extremity chronic venous disorders", section on 'Villalta scale'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13830240">
         <span class="h2">
          D-dimer
         </span>
         <span class="headingEndMark">
          —
         </span>
         D-dimers are detectable at levels greater than 500 ng/mL (ie, 500 mcg/L) of fibrinogen equivalent units in nearly all patients with venous thromboembolism but are nonspecific for post-thrombotic syndrome. Elevated D-dimer measured in the absence of oral anticoagulants may also be predictive of recurrent venous thromboembolism [
         <a href="#rid77">
          77,78
         </a>
         ].
        </p>
        <p>
         An elevated D-dimer level may signal persistent activation of clotting or inflammatory pathways and is thought by some to be a predictor of post-thrombotic syndrome [
         <a href="#rid35">
          35,79
         </a>
         ]. In one study, 45 percent of 305 patients with acute, symptomatic DVT developed post-thrombotic syndrome as determined by the Villalta scale. Mean D-dimer at four-month follow-up was significantly higher in patients who developed post-thrombotic syndrome compared with those who did not (712 versus 444 mcg/L) [
         <a href="#rid79">
          79
         </a>
         ]. D-dimer levels were affected by
         <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">
          warfarin
         </a>
         administration, with lower levels seen in patients taking warfarin (with or without post-thrombotic syndrome). (See
         <a class="medical medical_review" href="/z/d/html/8177.html" rel="external">
          "Classification of lower extremity chronic venous disorders", section on 'Villalta scale'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H93644033">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of post-thrombotic syndrome is predominantly clinical [
         <a href="#rid1">
          1,7
         </a>
         ]. In patients with a known history of deep vein thrombosis (DVT)
         <strong>
          and
         </strong>
         obvious symptoms/signs of chronic venous insufficiency, a clinical diagnosis of post-thrombotic syndrome can be made; additional diagnostic testing is generally not necessary [
         <a href="#rid7">
          7
         </a>
         ]. Because the symptoms of post-thrombotic syndrome can be variable over time and can be similar to those of an acute DVT, expert consensus is to wait up to six months following an acute DVT before making a diagnosis [
         <a href="#rid6">
          6
         </a>
         ]. Venous imaging, typically duplex ultrasound, may be useful for patients in whom the clinical signs of chronic venous insufficiency are not obvious, those with a clinical history that suggests DVT but for whom diagnostic testing was not performed, and in those with severe symptoms.
        </p>
        <p>
         For those without an objectively proven prior DVT, duplex ultrasound can often diagnose or exclude a prior DVT [
         <a href="#rid7">
          7,80
         </a>
         ]. Incompressibility indicates a high likelihood of a proximal vein thrombosis. For patients with normal venous compression, findings of popliteal reflux and/or a Villalta score &gt;8 (see
         <a class="local">
          'Scoring systems'
         </a>
         above) is highly specific for a prior DVT [
         <a href="#rid80">
          80
         </a>
         ]. In the absence of symptoms, venous abnormalities alone, such as venous reflux, persistent venous obstruction, or both as shown by invasive or noninvasive diagnostic studies, do not allow a patient with a history of DVT to be defined as having post-thrombotic syndrome [
         <a href="#rid81">
          81
         </a>
         ]. If there is no evidence of venous reflux or obstruction on imaging or physiologic studies, patients with lower extremity symptoms associated with swelling may have another etiology. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p>
         In patients with severe symptoms, it may be worth investigating whether the patient has a venous abnormality that may benefit from intervention, such as a residual iliac vein stenosis or occlusion, or proximal venous reflux. Venous duplex and intravascular ultrasound along with venography are the main imaging modalities for assessing obstruction or venous reflux in patients with post-thrombotic syndrome. (See
         <a class="local">
          'Treatment'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H13830185">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical conditions that may result in symptoms and signs of lower extremity pain, fatigue, or swelling include primary venous insufficiency, increased body mass index leading to lipedema (lipoedema), lymphedema, tumor or arterial aneurysm causing venous obstruction, Baker's cyst, and extremity injury, among others.
        </p>
        <p>
         Given that the clinical symptoms and signs and venous duplex findings are nonspecific, a history of deep vein thrombosis (DVT) alone distinguishes post-thrombotic syndrome as a secondary cause of venous insufficiency from primary venous insufficiency, for which there is not an obvious inciting factor, and the other entities listed above. (See
         <a class="medical medical_review" href="/z/d/html/8198.html" rel="external">
          "Clinical manifestations of lower extremity chronic venous disease", section on 'Approach to the patient'
         </a>
         .)
        </p>
        <p>
         Masses leading to venous obstruction, such as those caused by arterial aneurysm, Baker's cyst, or tumor, may be obvious during physical examination of the groin and popliteal fossa but difficult to identify in patients who are obese or have significant extremity swelling. These, as well as obstructing pelvic masses, can be identified using ultrasound, or cross-sectional imaging if needed. (See
         <a class="medical medical_review" href="/z/d/html/15187.html" rel="external">
          "Popliteal artery aneurysm"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14924.html" rel="external">
          "Popliteal (Baker's) cyst"
         </a>
         .)
        </p>
        <p>
         Conditions that can cause lower extremity edema and lymphedema are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/6878.html" rel="external">
          "Clinical manifestations and evaluation of edema in adults", section on 'Peripheral edema'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/755.html" rel="external">
          "Clinical features and diagnosis of peripheral lymphedema"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          TREATMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Conservative management of venous insufficiency as a result of post-thrombotic syndrome is similar to that of other patients with chronic venous disease and is discussed in detail elsewhere. Conservative management includes exercise, limb elevation, compression therapy, and possibly pharmacologic therapy [
         <a href="#rid81">
          81,82
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H234405203">
         <span class="h2">
          Exercise
         </span>
         <span class="headingEndMark">
          —
         </span>
         Exercise training may improve symptoms of post-thrombotic
         <sup>
         </sup>
         syndrome [
         <a href="#rid83">
          83
         </a>
         ]. Patients should be encouraged to exercise (ankle flexion, walking) to increase calf muscle strength, leg flexibility and overall cardiovascular fitness, and to elevate the extremity when at rest.
        </p>
        <p class="headingAnchor" id="H292211006">
         <span class="h2">
          Compression therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Once a diagnosis of post-thrombotic syndrome is established, compression therapy is the cornerstone of managing symptoms and the sequelae of chronic venous disease, including post-thrombotic syndrome [
         <a href="#rid81">
          81,82,84
         </a>
         ]. Commonly used forms of compression include compression stockings, short stretch bandages, zinc paste bandages (eg,
         <a class="drug drug_general" data-topicid="10056" href="/z/d/drug information/10056.html" rel="external">
          Unna boot
         </a>
         ), and multilayer compression. The choice depends upon the severity of symptoms and presence of edema, skin changes, or ulceration. In one trial, 93 percent of the patients, each of whom was motivated to prevent the long-term sequelae of deep vein thrombosis, were compliant with their prescribed compression regimen [
         <a href="#rid85">
          85
         </a>
         ]. Compliance is particularly important for patients with ulceration to achieve ulcer healing and prevent ulcer recurrence. Compression therapy for the treatment of chronic venous insufficiency is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/15199.html" rel="external">
          "Compression therapy for the treatment of chronic venous insufficiency", section on 'Static compression therapy'
         </a>
         .)
        </p>
        <p>
         Intermittent pneumatic compression or lymphedema therapy may offer symptomatic relief for patients with moderate-to-severe post-thrombotic syndrome [
         <a href="#rid86">
          86
         </a>
         ]. In a small clinical trial conducted in patients with severe post-thrombotic syndrome, intermittent pneumatic compression reduced intractable edema [
         <a href="#rid87">
          87
         </a>
         ]. In a later trial, a novel lower limb venous-return assist device improved the clinical manifestations of severe post-thrombotic syndrome alone and in combination with compression stockings [
         <a href="#rid88">
          88
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15199.html" rel="external">
          "Compression therapy for the treatment of chronic venous insufficiency", section on 'Dynamic compression therapy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H234406986">
         <span class="h2">
          Pharmacologic therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of pharmacologic agents have been used in the treatment of chronic venous disease to aid with lower extremity symptoms, as well as for the local treatment of skin changes and venous ulceration. For patients who are unable to tolerate, are not compliant with, or in whom compression therapy is contraindicated (eg, occlusive arterial disease), we suggest escin (ie, horse chestnut seed extract).
        </p>
        <p class="headingAnchor" id="H292210816">
         <span class="h2">
          Skin and ulcer care
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dry skin, itching, and eczematous changes are treated with moisturizers and, if needed, a midpotency topical corticosteroid. We suggest avoiding topical products with common sensitizers (eg,
         <a class="drug drug_general" data-topicid="101844" href="/z/d/drug information/101844.html" rel="external">
          lanolin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9686" href="/z/d/drug information/9686.html" rel="external">
          neomycin
         </a>
         , nickel). When venous insufficiency is associated with severe edema, weeping, eczema, or ulceration, compression stockings or elastic or nonelastic compression bandages are used. When compression bandages are chosen, we suggest multilayered compression bandages rather than single-layer bandages. (See
         <a class="medical medical_review" href="/z/d/html/15199.html" rel="external">
          "Compression therapy for the treatment of chronic venous insufficiency"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/127144.html" rel="external">
          "Evaluation and management of chronic venous insufficiency including venous leg ulcer", section on 'Ulcer care'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13830837">
         <span class="h2">
          Venous intervention
         </span>
         <span class="headingEndMark">
          —
         </span>
         Endovascular or surgical interventions in appropriately selected patients with venous obstruction or reflux may decrease the incidence of recurrent ulceration and skin changes and improve quality of life in patients with chronic venous disease. In the past, venous interventions were reported to have inferior results in patients with post-thrombotic syndrome compared with treatment of primary venous insufficiency [
         <a href="#rid89">
          89,90
         </a>
         ]. However, these older studies involved primarily open venous procedures, and the newer procedures have not been well studied in trials that specifically evaluate outcomes in patients with post-thrombotic syndrome.
        </p>
        <p>
         If venous outflow obstruction is present, it should be addressed first. Occluded or stenotic iliac vein segments can be treated using percutaneous angioplasty with or without stenting, venous bypass, or endophlebectomy [
         <a href="#rid76">
          76,91-96
         </a>
         ]. In a study of 44 patients (of whom eight had post-thrombotic syndrome), the technical success rate for iliac venous stenting was 95 percent [
         <a href="#rid91">
          91
         </a>
         ]. Venous clinical severity scores in treated patients were improved from a median score of 8.5 to 2, and the median venous disability score improved from 2 to 0. Primary, assisted primary, and secondary patency rates of the treated venous segments at three years were 73, 88, and 90 percent, respectively. The results were not stratified by the etiology of the venous disease. In another study of 82 limbs in 78 patients, successful recanalization of chronic venous obstruction improved venous quality measures [
         <a href="#rid97">
          97
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15222.html" rel="external">
          "Endovenous intervention for iliocaval venous obstruction"
         </a>
         .)
        </p>
        <p>
         Surgical vein bypass is an option for selected patients with severe proximal venous reflux, but only if percutaneous intervention has failed to restore flow; however, it is limited to certain high-volume referral centers [
         <a href="#rid96">
          96,98-100
         </a>
         ]. Venous valve reconstruction (including valve transplant, valvuloplasty, and endograft valves) has been largely unsuccessful in the treatment of these patients and has been abandoned by many of the original advocates. (See
         <a class="medical medical_review" href="/z/d/html/15225.html" rel="external">
          "Techniques used for open iliocaval venous reconstruction"
         </a>
         .)
        </p>
        <p>
         Focal symptoms and patients with venous ulceration may benefit from treatment of incompetent superficial veins. Ablation procedures are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/8206.html" rel="external">
          "Injection sclerotherapy techniques for the treatment of telangiectasias, reticular veins, and small varicose veins"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8203.html" rel="external">
          "Techniques for radiofrequency ablation for the treatment of lower extremity chronic venous disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15198.html" rel="external">
          "Techniques for endovenous laser ablation for the treatment of lower extremity chronic venous disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/121344.html" rel="external">
          "Approach to treating symptomatic superficial venous insufficiency", section on 'Intervention for axial vein reflux'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13830845">
         <span class="h1">
          PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         When patients are prescribed elastic compression stockings and are supervised appropriately, more than 50 percent of patients remain stable or improve during long-term follow-up, regardless of the initial severity of the post-thrombotic syndrome [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H234405743">
         <span class="h2">
          Quality of life
         </span>
         <span class="headingEndMark">
          —
         </span>
         Post-thrombotic syndrome causes significant disability and economic burden for patients and the health care system [
         <a href="#rid101">
          101,102
         </a>
         ]. Chronic venous insufficiency, including that due to post-thrombotic syndrome, can have a significant negative effect on quality of life [
         <a href="#rid46">
          46,101,103,104
         </a>
         ]. In a study of patients two years after treatment for deep venous thrombosis, quality-of-life measures of patients with post-thrombotic syndrome were comparable to published norms for those with angina, cancer, or heart failure [
         <a href="#rid103">
          103
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3468380808">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/113663.html" rel="external">
          "Society guideline links: Superficial vein thrombosis, deep vein thrombosis, and pulmonary embolism"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/118466.html" rel="external">
          "Society guideline links: Chronic venous disorders"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Post-thrombotic syndrome consists of symptoms and signs of chronic venous insufficiency that develop following deep vein thrombosis (DVT) and is a consequence of long-standing venous hypertension thought to be due to a combination of thrombotic vein occlusion and venous valvular incompetence. Post-thrombotic syndrome occurs in up to 50 percent of patients within the first year following acute thrombosis, in spite of anticoagulation. Severe post-thrombotic syndrome develops in 5 to 10 percent of patients. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Pathophysiology'
         </a>
         above and
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patient characteristics that may be important for the development of post-thrombotic syndrome include primary venous insufficiency, older age, obesity, and preexisting varicose veins. The most important factors related to the inciting DVT include proximal DVT, moderate-severe Villalta severity category at DVT diagnosis, inadequate anticoagulation during initial treatment of DVT, residual thrombus in the vein, and recurrent DVT. (See
         <a class="local">
          'Risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The clinical manifestations of post-thrombotic syndrome are those of chronic venous insufficiency and may include extremity pain, limb heaviness, vein dilation, extremity edema, skin pigmentation, trophic skin changes, and venous ulcers. Edema is the most common manifestation, occurring in approximately two thirds of patients. (See
         <a class="local">
          'Clinical features'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/8198.html" rel="external">
          "Clinical manifestations of lower extremity chronic venous disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A diagnosis of post-thrombotic syndrome is predominantly clinical. For patients with a known history of DVT and obvious symptoms/signs of chronic venous insufficiency, a clinical diagnosis of post-thrombotic syndrome can be made; additional diagnostic testing is generally not necessary. However, venous imaging, typically duplex ultrasound, may be useful for patients in whom the clinical signs of chronic venous insufficiency are not obvious, those with a clinical history that suggests DVT but in whom studies were not performed, or to identify proximal vein stenosis or occlusion in those with severe symptoms. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The management of patients with venous insufficiency as a result of post-thrombotic syndrome is similar to that for other patients with chronic venous disease and includes limb elevation, exercise, compression therapy, and possibly pharmacologic therapy. The choice of compression therapy depends upon the severity of symptoms and presence of edema, skin changes, or ulceration. Recommendations for treating chronic venous insufficiency are listed below and discussed in detail elsewhere. (See
         <a class="local">
          'Treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For all patients with chronic venous symptoms, we suggest leg elevation (when possible), leg exercises (ankle flexion, walking) to increase calf muscle strength, and graduated compression stockings (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/15199.html" rel="external">
          "Compression therapy for the treatment of chronic venous insufficiency", section on 'Static compression therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients who are unable to tolerate compression therapy, are not compliant with compression therapy, or in whom compression therapy is contraindicated (eg, occlusive arterial disease), we suggest horse chestnut seed extract (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). A typical dose is 300 mg (standardized to 50 mg of escin) twice daily.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dry skin, itching, and eczematous changes are treated with moisturizers and, if needed, a midpotency topical corticosteroid. We suggest avoiding topical products with common sensitizers (eg,
         <a class="drug drug_general" data-topicid="101844" href="/z/d/drug information/101844.html" rel="external">
          lanolin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9686" href="/z/d/drug information/9686.html" rel="external">
          neomycin
         </a>
         , nickel) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         When venous insufficiency is associated with severe edema, weeping, eczema, or ulceration, compression stockings or elastic or nonelastic compression bandages are used. When compression bandages are chosen, we suggest multilayered compression bandages rather than single-layer bandages (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/15199.html" rel="external">
          "Compression therapy for the treatment of chronic venous insufficiency"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15199.html" rel="external">
          "Compression therapy for the treatment of chronic venous insufficiency", section on 'Compression bandages'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with severe symptoms and evidence of proximal vein stenosis or occlusion on vein imaging studies, venous intervention may decrease the incidence of skin changes and ulceration and improve quality of life. (See
         <a class="local">
          'Venous intervention'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/15222.html" rel="external">
          "Endovenous intervention for iliocaval venous obstruction"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H318691369">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The editorial staff at UpToDate would like to acknowledge Patrick C Alguire, MD, FACP, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Kahn SR, Partsch H, Vedantham S, et al. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost 2009; 7:879.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grosse SD, Nelson RE, Nyarko KA, et al. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. Thromb Res 2016; 137:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Porter JM, Moneta GL. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg 1995; 21:635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Franzeck UK, Schalch I, Jäger KA, et al. Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zürich study). Circulation 1996; 93:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bergan JJ, Schmid-Schönbein GW, Smith PD, et al. Chronic venous disease. N Engl J Med 2006; 355:488.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn SR, Comerota AJ, Cushman M, et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 2014; 130:1636.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prandoni P, Kahn SR. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol 2009; 145:286.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamaki T, Nozaki M, Sakurai H, et al. High peak reflux velocity in the proximal deep veins is a strong predictor of advanced post-thrombotic sequelae. J Thromb Haemost 2007; 5:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nicolaides AN, Hussein MK, Szendro G, et al. The relation of venous ulceration with ambulatory venous pressure measurements. J Vasc Surg 1993; 17:414.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Araki CT, Back TL, Padberg FT, et al. The significance of calf muscle pump function in venous ulceration. J Vasc Surg 1994; 20:872.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Welkie JF, Comerota AJ, Katz ML, et al. Hemodynamic deterioration in chronic venous disease. J Vasc Surg 1992; 16:733.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chandrashekar A, Garry J, Gasparis A, Labropoulos N. Vein wall remodeling in patients with acute deep vein thrombosis and chronic postthrombotic changes. J Thromb Haemost 2017; 15:1989.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roumen-Klappe EM, Janssen MC, Van Rossum J, et al. Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: a prospective study. J Thromb Haemost 2009; 7:582.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shbaklo H, Holcroft CA, Kahn SR. Levels of inflammatory markers and the development of the post-thrombotic syndrome. Thromb Haemost 2009; 101:505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn SR, Shbaklo H, Shapiro S, et al. Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial. BMC Cardiovasc Disord 2007; 7:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Markel A, Manzo RA, Bergelin RO, Strandness DE Jr. Valvular reflux after deep vein thrombosis: incidence and time of occurrence. J Vasc Surg 1992; 15:377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prandoni P, Frulla M, Sartor D, et al. Vein abnormalities and the post-thrombotic syndrome. J Thromb Haemost 2005; 3:401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roumen-Klappe EM, den Heijer M, Janssen MC, et al. The post-thrombotic syndrome: incidence and prognostic value of non-invasive venous examinations in a six-year follow-up study. Thromb Haemost 2005; 94:825.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meissner MH, Zierler BK, Bergelin RO, et al. Coagulation, fibrinolysis, and recanalization after acute deep venous thrombosis. J Vasc Surg 2002; 35:278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Killewich LA, Macko RF, Cox K, et al. Regression of proximal deep venous thrombosis is associated with fibrinolytic enhancement. J Vasc Surg 1997; 26:861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh H, Masuda EM. Comparing short-term outcomes of femoral-popliteal and iliofemoral deep venous thrombosis: early lysis and development of reflux. Ann Vasc Surg 2005; 19:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'shaughnessy AM, Fitzgerald DE. The patterns and distribution of residual abnormalities between the individual proximal venous segments after an acute deep vein thrombosis. J Vasc Surg 2001; 33:379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meissner MH, Manzo RA, Bergelin RO, et al. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg 1993; 18:596.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Ramshorst B, van Bemmelen PS, Hoeneveld H, et al. Thrombus regression in deep venous thrombosis. Quantification of spontaneous thrombolysis with duplex scanning. Circulation 1992; 86:414.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meissner MH, Caps MT, Zierler BK, et al. Determinants of chronic venous disease after acute deep venous thrombosis. J Vasc Surg 1998; 28:826.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Markel A, Meissner M, Manzo RA, et al. Deep venous thrombosis: rate of spontaneous lysis and thrombus extension. Int Angiol 2003; 22:376.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tick LW, Doggen CJ, Rosendaal FR, et al. Predictors of the post-thrombotic syndrome with non-invasive venous examinations in patients 6 weeks after a first episode of deep vein thrombosis. J Thromb Haemost 2010; 8:2685.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashrani AA, Heit JA. Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis 2009; 28:465.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baldwin MJ, Moore HM, Rudarakanchana N, et al. Post-thrombotic syndrome: a clinical review. J Thromb Haemost 2013; 11:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn SR, Kearon C, Julian JA, et al. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost 2005; 3:718.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Partsch H, Kaulich M, Mayer W. Immediate mobilisation in acute vein thrombosis reduces post-thrombotic syndrome. Int Angiol 2004; 23:206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tick LW, Kramer MH, Rosendaal FR, et al. Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis. J Thromb Haemost 2008; 6:2075.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn SR, Shrier I, Julian JA, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008; 149:698.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stain M, Schönauer V, Minar E, et al. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost 2005; 3:2671.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ziegler S, Schillinger M, Maca TH, Minar E. Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago. Thromb Res 2001; 101:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asbeutah AM, Riha AZ, Cameron JD, McGrath BP. Five-year outcome study of deep vein thrombosis in the lower limbs. J Vasc Surg 2004; 40:1184.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Rij AM, Hill G, Krysa J, et al. Prospective study of natural history of deep vein thrombosis: early predictors of poor late outcomes. Ann Vasc Surg 2013; 27:924.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn SR. The post-thrombotic syndrome: progress and pitfalls. Br J Haematol 2006; 134:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rabinovich A, Ducruet T, Kahn SR, SOX Trial investigators. Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis. J Thromb Haemost 2018; 16:262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rabinovich A, Gu CS, Vedantham S, et al. External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis. J Thromb Haemost 2020; 18:1381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Dongen CJ, Prandoni P, Frulla M, et al. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost 2005; 3:939.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prandoni P, Lensing AW, Prins MH, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004; 141:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ageno W, Piantanida E, Dentali F, et al. Body mass index is associated with the development of the post-thrombotic syndrome. Thromb Haemost 2003; 89:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Galanaud JP, Holcroft CA, Rodger MA, et al. Comparison of the Villalta post-thrombotic syndrome score in the ipsilateral vs. contralateral leg after a first unprovoked deep vein thrombosis. J Thromb Haemost 2012; 10:1036.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 2002; 162:1144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spiezia L, Campello E, Giolo E, et al. Thrombophilia and the risk of post-thrombotic syndrome: retrospective cohort observation. J Thromb Haemost 2010; 8:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Labropoulos N, Jen J, Jen H, et al. Recurrent deep vein thrombosis: long-term incidence and natural history. Ann Surg 2010; 251:749.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Labropoulos N, Gasparis AP, Tassiopoulos AK. Prospective evaluation of the clinical deterioration in post-thrombotic limbs. J Vasc Surg 2009; 50:826.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Labropoulos N, Gasparis AP, Pefanis D, et al. Secondary chronic venous disease progresses faster than primary. J Vasc Surg 2009; 49:704.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ginsberg JS, Hirsh J, Julian J, et al. Prevention and treatment of postphlebitic syndrome: results of a 3-part study. Arch Intern Med 2001; 161:2105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wille-Jørgensen P, Jorgensen LN, Crawford M. Asymptomatic postoperative deep vein thrombosis and the development of postthrombotic syndrome. A systematic review and meta-analysis. Thromb Haemost 2005; 93:236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strandness DE Jr, Langlois Y, Cramer M, et al. Long-term sequelae of acute venous thrombosis. JAMA 1983; 250:1289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson BF, Manzo RA, Bergelin RO, Strandness DE Jr. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up. J Vasc Surg 1995; 21:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Ramshorst B, van Bemmelen PS, Hoeneveld H, Eikelboom BC. The development of valvular incompetence after deep vein thrombosis: a follow-up study with duplex scanning. J Vasc Surg 1994; 19:1059.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McEnroe CS, O'Donnell TF Jr, Mackey WC. Correlation of clinical findings with venous hemodynamics in 386 patients with chronic venous insufficiency. Am J Surg 1988; 156:148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sethia KK, Darke SG. Long saphenous incompetence as a cause of venous ulceration. Br J Surg 1984; 71:754.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Labropoulos N, Leon M, Geroulakos G, et al. Venous hemodynamic abnormalities in patients with leg ulceration. Am J Surg 1995; 169:572.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Philbrick JT, Becker DM. Calf deep venous thrombosis. A wolf in sheep's clothing? Arch Intern Med 1988; 148:2131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McLafferty RB, Moneta GL, Passman MA, et al. Late clinical and hemodynamic sequelae of isolated calf vein thrombosis. J Vasc Surg 1998; 27:50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amin EE, Bistervels IM, Meijer K, et al. Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis. Blood 2018; 132:2298.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chitsike RS, Rodger MA, Kovacs MJ, et al. Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study. J Thromb Haemost 2012; 10:2039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baglin T. Prevention of post-thrombotic syndrome: a case for new oral anticoagulant drugs or for heparins? J Thromb Haemost 2012; 10:1702.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheung YW, Middeldorp S, Prins MH, et al. Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis. Thromb Haemost 2016; 116:733.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rennenberg RJ. Oral anticoagulants, effect on thrombus resolution and post-thrombotic syndrome. Phlebology 2016; 31:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prandoni P, Ageno W, Ciammaichella M, et al. The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants. Intern Emerg Med 2020; 15:447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wik HS, Kahn SR, Eriksson H, et al. Post-thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long-term cross-sectional follow-up of RE-COVER study patients. J Thromb Haemost 2021; 19:2495.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karathanos C, Nana P, Spanos K, et al. Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: A systematic review and meta-analysis. J Vasc Surg Venous Lymphat Disord 2021; 9:1568.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hull RD, Liang J, Townshend G. Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review. Am J Med 2011; 124:756.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           González-Fajardo JA, Martin-Pedrosa M, Castrodeza J, et al. Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin. J Vasc Surg 2008; 48:953.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Enden T, Haig Y, Kløw NE, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012; 379:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Notten P, Ten Cate-Hoek AJ, Arnoldussen CWKP, et al. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial. Lancet Haematol 2020; 7:e40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brandjes DP, Büller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349:759.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn SR, Shapiro S, Wells PS, et al. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet 2014; 383:880.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ten Cate-Hoek AJ, Amin EE, Bouman AC, et al. Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial. Lancet Haematol 2018; 5:e25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henke PK, Comerota AJ. An update on etiology, prevention, and therapy of postthrombotic syndrome. J Vasc Surg 2011; 53:500.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verhovsek M, Douketis JD, Yi Q, et al. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med 2008; 149:481.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cosmi B, Legnani C, Tosetto A, et al. Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension. J Thromb Haemost 2010; 8:1933.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Latella J, Desmarais S, Miron MJ, et al. Relation between D-dimer level, venous valvular reflux and the development of post-thrombotic syndrome after deep vein thrombosis. J Thromb Haemost 2010; 8:2169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Villalta S, Prandoni P, Cogo A, et al. The utility of non-invasive tests for detection of previous proximal-vein thrombosis. Thromb Haemost 1995; 73:592.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn SR. How I treat postthrombotic syndrome. Blood 2009; 114:4624.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen JM, Akl EA, Kahn SR. Pharmacologic and compression therapies for postthrombotic syndrome: a systematic review of randomized controlled trials. Chest 2012; 141:308.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn SR, Shrier I, Shapiro S, et al. Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial. CMAJ 2011; 183:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lattimer CR, Azzam M, Kalodiki E, et al. Compression stockings significantly improve hemodynamic performance in post-thrombotic syndrome irrespective of class or length. J Vasc Surg 2013; 58:158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mol GC, van de Ree MA, Klok FA, et al. One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study): randomised controlled trial. BMJ 2016; 353:i2691.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holmes CE, Bambace NM, Lewis P, et al. Efficacy of a short course of complex lymphedema therapy or graduated compression stocking therapy in the treatment of post-thrombotic syndrome. Vasc Med 2014; 19:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ginsberg JS, Magier D, Mackinnon B, et al. Intermittent compression units for severe post-phlebitic syndrome: a randomized crossover study. CMAJ 1999; 160:1303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levi M. A long-awaited small step forward in the management of the post-thrombotic syndrome. Thromb Haemost 2008; 99:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gloviczki P, Bergan JJ, Rhodes JM, et al. Mid-term results of endoscopic perforator vein interruption for chronic venous insufficiency: lessons learned from the North American subfascial endoscopic perforator surgery registry. The North American Study Group. J Vasc Surg 1999; 29:489.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perrin M, Hiltbrand B, Bayon JM. Results of valvuloplasty in patients presenting deep venous insufficiency and recurring ulceration. Ann Vasc Surg 1999; 13:524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hartung O, Otero A, Boufi M, et al. Mid-term results of endovascular treatment for symptomatic chronic nonmalignant iliocaval venous occlusive disease. J Vasc Surg 2005; 42:1138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Razavi MK, Jaff MR, Miller LE. Safety and Effectiveness of Stent Placement for Iliofemoral Venous Outflow Obstruction: Systematic Review and Meta-Analysis. Circ Cardiovasc Interv 2015; 8:e002772.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meissner MH, Gloviczki P, Comerota AJ, et al. Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2012; 55:1449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casey ET, Murad MH, Zumaeta-Garcia M, et al. Treatment of acute iliofemoral deep vein thrombosis. J Vasc Surg 2012; 55:1463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nayak L, Hildebolt CF, Vedantham S. Postthrombotic syndrome: feasibility of a strategy of imaging-guided endovascular intervention. J Vasc Interv Radiol 2012; 23:1165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khanna AK, Singh S. Postthrombotic syndrome: surgical possibilities. Thrombosis 2012; 2012:520604.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garcia MJ, Sterling KM, Kahn SR, et al. Ultrasound-Accelerated Thrombolysis and Venoplasty for the Treatment of the Postthrombotic Syndrome: Results of the ACCESS PTS Study. J Am Heart Assoc 2020; 9:e013398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raju S, Fredericks RK, Neglèn PN, Bass JD. Durability of venous valve reconstruction techniques for "primary" and postthrombotic reflux. J Vasc Surg 1996; 23:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raju S, Neglén P, Doolittle J, Meydrech EF. Axillary vein transfer in trabeculated postthrombotic veins. J Vasc Surg 1999; 29:1050.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bry JD, Muto PA, O'Donnell TF, Isaacson LA. The clinical and hemodynamic results after axillary-to-popliteal vein valve transplantation. J Vasc Surg 1995; 21:110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 2004; 164:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bergqvist D, Jendteg S, Johansen L, et al. Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Intern Med 1997; 126:454.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn SR, Shbaklo H, Lamping DL, et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 2008; 6:1105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashrani AA, Silverstein MD, Rooke TW, et al. Impact of venous thromboembolism, venous stasis syndrome, venous outflow obstruction and venous valvular incompetence on quality of life and activities of daily living: a nested case-control study. Vasc Med 2010; 15:387.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 8200 Version 26.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19175497" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26654719" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7707568" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8616945" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zürich study).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16885552" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Chronic venous disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25246013" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19222476" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Post-thrombotic syndrome: prevalence, prognostication and need for progress.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17155956" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : High peak reflux velocity in the proximal deep veins is a strong predictor of advanced post-thrombotic sequelae.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8433436" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The relation of venous ulceration with ambulatory venous pressure measurements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7990181" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : The significance of calf muscle pump function in venous ulceration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1433661" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Hemodynamic deterioration in chronic venous disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28787773" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Vein wall remodeling in patients with acute deep vein thrombosis and chronic postthrombotic changes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19175493" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19277412" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Levels of inflammatory markers and the development of the post-thrombotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17711595" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1735898" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Valvular reflux after deep vein thrombosis: incidence and time of occurrence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15670059" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Vein abnormalities and the post-thrombotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16270638" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The post-thrombotic syndrome: incidence and prognostic value of non-invasive venous examinations in a six-year follow-up study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11854725" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Coagulation, fibrinolysis, and recanalization after acute deep venous thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9372826" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Regression of proximal deep venous thrombosis is associated with fibrinolytic enhancement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15714371" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Comparing short-term outcomes of femoral-popliteal and iliofemoral deep venous thrombosis: early lysis and development of reflux.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11174793" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : The patterns and distribution of residual abnormalities between the individual proximal venous segments after an acute deep vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8411467" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Deep venous insufficiency: the relationship between lysis and subsequent reflux.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1638710" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Thrombus regression in deep venous thrombosis. Quantification of spontaneous thrombolysis with duplex scanning.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9808849" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Determinants of chronic venous disease after acute deep venous thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15153822" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Deep venous thrombosis: rate of spontaneous lysis and thrombus extension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20860679" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Predictors of the post-thrombotic syndrome with non-invasive venous examinations in patients 6 weeks after a first episode of deep vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19224134" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Incidence and cost burden of post-thrombotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23433231" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Post-thrombotic syndrome: a clinical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15733061" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15765034" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Immediate mobilisation in acute vein thrombosis reduces post-thrombotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8644983" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : The long-term clinical course of acute deep venous thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18983518" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19017588" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16359506" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11342203" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15622373" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Five-year outcome study of deep vein thrombosis in the lower limbs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23816387" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Prospective study of natural history of deep vein thrombosis: early predictors of poor late outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16822286" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : The post-thrombotic syndrome: progress and pitfalls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29193770" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32145144" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15869588" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15313740" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12574811" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Body mass index is associated with the development of the post-thrombotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22646832" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Comparison of the Villalta post-thrombotic syndrome score in the ipsilateral vs. contralateral leg after a first unprovoked deep vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12020185" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19874465" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Thrombophilia and the risk of post-thrombotic syndrome: retrospective cohort observation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20224361" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Recurrent deep vein thrombosis: long-term incidence and natural history.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19628354" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Prospective evaluation of the clinical deterioration in post-thrombotic limbs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19268774" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Secondary chronic venous disease progresses faster than primary.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11570939" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Prevention and treatment of postphlebitic syndrome: results of a 3-part study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15711738" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Asymptomatic postoperative deep vein thrombosis and the development of postthrombotic syndrome. A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6876315" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Long-term sequelae of acute venous thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7853603" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8201707" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The development of valvular incompetence after deep vein thrombosis: a follow-up study with duplex scanning.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3400816" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Correlation of clinical findings with venous hemodynamics in 386 patients with chronic venous insufficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6487973" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Long saphenous incompetence as a cause of venous ulceration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7771618" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Venous hemodynamic abnormalities in patients with leg ulceration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3052345" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Calf deep venous thrombosis. A wolf in sheep's clothing?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9474082" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Late clinical and hemodynamic sequelae of isolated calf vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30237155" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22846068" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22672412" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Prevention of post-thrombotic syndrome: a case for new oral anticoagulant drugs or for heparins?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27583311" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26916765" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Oral anticoagulants, effect on thrombus resolution and post-thrombotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31667697" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34255420" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Post-thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long-term cross-sectional follow-up of RE-COVER study patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33965611" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21787905" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18639417" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22172244" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31786086" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9074574" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24315521" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29217387" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21129900" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : An update on etiology, prevention, and therapy of postthrombotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18838728" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20553388" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20670369" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Relation between D-dimer level, venous valvular reflux and the development of post-thrombotic syndrome after deep vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7495064" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : The utility of non-invasive tests for detection of previous proximal-vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19741190" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : How I treat postthrombotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22315114" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Pharmacologic and compression therapies for postthrombotic syndrome: a systematic review of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21098066" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23414697" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Compression stockings significantly improve hemodynamic performance in post-thrombotic syndrome irrespective of class or length.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27245485" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study): randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24558028" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Efficacy of a short course of complex lymphedema therapy or graduated compression stocking therapy in the treatment of post-thrombotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10333832" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Intermittent compression units for severe post-phlebitic syndrome: a randomized crossover study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18327391" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : A long-awaited small step forward in the management of the post-thrombotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10069914" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Mid-term results of endoscopic perforator vein interruption for chronic venous insufficiency: lessons learned from the North American subfascial endoscopic perforator surgery registry. The North American Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10466996" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Results of valvuloplasty in patients presenting deep venous insufficiency and recurring ulceration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16376204" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Mid-term results of endovascular treatment for symptomatic chronic nonmalignant iliocaval venous occlusive disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26438686" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Safety and Effectiveness of Stent Placement for Iliofemoral Venous Outflow Obstruction: Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22469503" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22440631" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Treatment of acute iliofemoral deep vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22841898" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Postthrombotic syndrome: feasibility of a strategy of imaging-guided endovascular intervention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22084674" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Postthrombotic syndrome: surgical possibilities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31983322" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Ultrasound-Accelerated Thrombolysis and Venoplasty for the Treatment of the Postthrombotic Syndrome: Results of the ACCESS PTS Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8637114" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Durability of venous valve reconstruction techniques for "primary" and postthrombotic reflux.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10359939" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Axillary vein transfer in trabeculated postthrombotic veins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7823349" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : The clinical and hemodynamic results after axillary-to-popliteal vein valve transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14718318" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Relationship between deep venous thrombosis and the postthrombotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9072931" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18466316" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Determinants of health-related quality of life during the 2 years following deep vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20926498" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Impact of venous thromboembolism, venous stasis syndrome, venous outflow obstruction and venous valvular incompetence on quality of life and activities of daily living: a nested case-control study.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
